+28.2%
MRNA vs ALLE
+44.7%
-16.5%
-86.6%
Performance
Returns, benchmark comparison, and relative performance.
Performance by timeframe
Returns for 3y.
| Period | Portfolio | ALLE | Excess | Alpha |
|---|---|---|---|---|
| 1D | -3.4% | -2.8% | -0.6% | -1.6% |
| 7D | -10.1% | -2.2% | -7.9% | -8.8% |
| 30D | +126.7% | -8.3% | +135.1% | +139.8% |
| 3M | +184.1% | +16.3% | +167.9% | +164.3% |
| 6M | +143.3% | +1.8% | +141.5% | +142.6% |
| YTD | +359.9% | -3.9% | +363.8% | +365.5% |
| 1Y | +454.2% | -10.0% | +464.2% | +487.2% |
| All | +28.2% | +44.7% | -16.5% | -6.7% |
Cumulative growth
Daily Returns
Daily percentage return beside ALLE.
Daily Out/Under-Performance
Portfolio return minus ALLE return. Positive bars indicate outperformance.
Daily Alpha
Portfolio daily return minus β × ALLE return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.
Cumulative Out/Under-Performance
Relative wealth over 3y: compounded portfolio wealth divided by compounded ALLE wealth, less one. Both series rebase at the selected span's start.
Cumulative Alpha
Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.
Updating return analytics…
3y analysis · Full analysis span regression · 6 months rolling